Your browser doesn't support javascript.
loading
Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial.
Malchair, Pierre; Giol, Jordi; García, Vanesa; Rodríguez, Orlando; Ruibal, José Carlos; Zarauza, Alvaro; Llopis, Ferrán; Matellán, Leire; Bernal, Tania; Solís, Beatriz; Otero, Aurema; Carnaval, Thiago; Jofre, Hector; Jacob, Javier; Solanich, Xavier; Antolí, Arnau; Rocamora, Gemma; Videla, Sebastián.
Affiliation
  • Malchair P; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Giol J; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • García V; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rodríguez O; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Ruibal JC; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Zarauza A; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Llopis F; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Matellán L; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Bernal T; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Solís B; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Otero A; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Carnaval T; Clinical Research Support Unit, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Jofre H; Clinical Research Support Unit, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Jacob J; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Solanich X; Radiology Department, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Antolí A; Emergency Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rocamora G; Internal Medicine Department, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Videla S; Internal Medicine Department, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
Clin Infect Dis ; 76(10): 1784-1792, 2023 05 24.
Article in En | MEDLINE | ID: mdl-36610464
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: Country of publication: